The validation study of the value of serum procalcitonin for predicting the prognosis of patients with pulmonary tuberculosis.

The validation study of the value of serum procalcitonin for predicting the prognosis of patients with pulmonary tuberculosis. - The validation study of the value of serum procalcitonin for predicting the prognosis of patients with pulmonary tuberculosis.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043849

Enrollment

160

Registered

2021-04-06

Start date

2021-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary tuberculosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Newly diagnosed active pulmonary tuberculosis, with or without extrapulmonary tuberculosis; and no treatment with antituberculosis agents on admission.

Exclusion criteria

Exclusion criteria: Disseminated tuberculosis (ie, positive M. tuberculosis PCR or culture test results for urine, blood, or cerebrospinal fluid) or a history of tuberculosis treatment in the 10 years before recruitment.

Design outcomes

Primary

Measure	Time frame
In-hospital mortality	—

Secondary

Measure	Time frame
Length of hospital stay Duration of sputum culture conversion of acid fast bacilli	—

Countries

Japan

Contacts

Public ContactTakeshi Osawa

Japan Anti-Tuberculosis Association (JATA), Fukujuji Hospital Department of Respiratory Medicine

take4.osawa@nifty.com0424914111

Outcome results